Mabion, a leading biotech-focused CDMO offering end-to-end services, has announced the launch of a €500,000 oncology services contest at BIO International Convention 2025, aimed at accelerating the development of recombinant protein-based cancer therapies. The contest will culminate at CPHI Worldwide in Frankfurt this October, spotlighting promising biotechs ready to scale their innovation. “Despite unprecedented […]
Post Type Archives: News
Lilly to acquire Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk
Verve’s leading programs aim to deliver lifelong cardiovascular risk reduction with a single dose by targeting genes strongly linked to cardiovascular disease Lilly’s established capabilities in cardiometabolic disease and genetic medicines are highly complementary to Verve’s vision and expertise Eli Lilly and Company and Verve Therapeutics, Inc., a Boston-based clinical-stage company developing genetic medicines for […]
Cellular Origins announces collaboration with Thermo Fisher Scientific to transform production output and labour requirements for CGT manufacturing using automated robotics manufacturing capabilities
Cellular Origins, a TTP Company, focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs), today announced an international collaboration with Thermo Fisher Scientific, the world leader in serving science. The collaboration will combine Thermo Fisher’s proven cell culture and processing technology and Cellular Origins’ CGT robotic manufacturing platform, Constellation, to deliver […]
Veranova Announces Strategic Investment to Establish cGMP Bioconjugation Capability in Devens, MA
Veranova, a global leader in the development and manufacturing of specialist and complex active pharmaceutical ingredients (APIs) for the pharmaceutical and biotech sectors, today announced a strategic investment to establish state-of-the-art bioconjugation development and cGMP manufacturing capacity at its Devens, Massachusetts campus. This expansion will enable Veranova to provide a more comprehensive suite of services […]
ECOLAB LIFE SCIENCES LAUNCHES NEW BIOPROCESSING PURIFICATION RESIN TO DRIVE MANUFACTURING PRODUCTIVITY
Ecolab Life Sciences announced it has launched an innovative new resin to help achieve cost savings and optimize operations throughout the antibody manufacturing process. Purolite™ AP+50 is an affinity chromatography resin with a 50-micron bead size offering the highest dynamic binding capacity of the AP resin platform while providing excellent durability for monoclonal antibody capture. […]
BIO Elects Genentech’s Fritz Bittenbender as New Board Chair
Today, the Biotechnology Innovation Organization (BIO) announced that Fritz Bittenbender, Senior Vice President and Head of Genentech Public Affairs and Access, has been elected Board Chair. Bittenbender assumes the Chair position from Ted W. Love, MD, former president and CEO of Global Blood Therapeutics (GBT), who held the position from 2023 to 2025 The announcement […]
Shilpa Medicare signs commercial supply deal with Orion for innovative Recombinant Human Albumin
Shilpa Biocare Private Limited, a fully-owned subsidiary of Shilpa Medicare Limited (“Shilpa”), announces ahead of BIO Boston that it has secured a Europe-wide commercial supply agreement with Orion Corporation for Recombinant Human Albumin. Shilpa’s Recombinant Human Albumin – a key plasma protein used in various therapeutic applications – is currently under development and will be […]
Strategic Alliance for Drug Substance and Drug Product ADC Manufacturing
With the development and clinical use of antibody-drug conjugates (ADCs) currently gaining significant momentum, the demand for contract development and manufacturing services continues to increase. In response, we have forged a strategic alliance with Simtra BioPharma Solutions to streamline and accelerate the delivery of these targeted therapies and other bioconjugates to patients. As two industry-leading […]
Nanoform starts Pivotal Human Bioequivalence Studies of Nanoenzalutamide
Nanoform Finland Plc, the medicine performance-enhancing company, today announced that it had started pivotal relative bioequivalence studies of Nanoenzalutamide, the nanocrystalline-enabled enzalutamide tablet formulation, a potential alternative to the amorphous solid dispersion (ASD) used in XTANDI® (enzalutamide) [1], the number one prescribed androgen receptor inhibitor [2] approved to treat prostate cancer. The studies are being conducted in […]
Ethris and Lonza Collaborate to Develop Spray-Dried mRNA Vaccines for Respiratory Disease Prevention
Ethris, a clinical-stage biotechnology company pioneering next-generation RNA therapeutics and vaccines, and Lonza, one of the world’s largest contract development and manufacturing organizations (CDMOs), announced a collaboration to develop room-temperature stable, spray-dried formulations of mRNA-based vaccine candidates, designed for mucosal delivery that offer a promising approach to combat respiratory diseases. Room-temperature stability aims to address […]